Get startedLog in
    Picture of Seelos Therapeutics logo

    SEELQ — Seelos Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Seelos Therapeutics Announces Strategic Device Partnership With AptarGroup Inc

    Picture of Seelos Therapeutics logoSeelos Therapeutics
    06/04/2021 12:06
    April 6 (Reuters) - Seelos Therapeutics Inc  SEEL.O :
    * SEELOS THERAPEUTICS ANNOUNCES A STRATEGIC DEVICE
PARTNERSHIP
WITH APTARGROUP, INC.
    * SEELOS THERAPEUTICS INC - STRATEGIC DEVICE PARTNERSHIP
ALLOWS
SEELOS TO USE APTAR PHARMA'S BIDOSE (BDS) LIQUID SYSTEM DEVICE
WITH SLS-002 PROGRAM
    * SEELOS THERAPEUTICS INC - SEELOS HAS CERTAIN RIGHTS TO ADD
OTHER
UNDISCLOSED INDICATIONS TO STRATEGIC DEVICE PARTNERSHIP
    * SEELOS THERAPEUTICS INC - EXPECTS TO RELEASE KEY
OPEN-LABEL DATA
IN Q2 OF 2021, AFTER ANALYZING DATA RECEIVED FROM PART 1 OF
STUDY

Source text for Eikon:  ID:nPn4t36c8a 
Further company coverage:  SEEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Seelos Therapeutics

    See all news